scholarly journals Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus

2007 ◽  
Vol 14 (1) ◽  
pp. 92-95 ◽  
Author(s):  
Vishal Bhagat ◽  
Julie A. Foont ◽  
Eugene R. Schiff ◽  
Arie Regev
2003 ◽  
Vol 35 (5) ◽  
pp. 1846-1847 ◽  
Author(s):  
R González Alonso ◽  
R Bárcena ◽  
C Blesa ◽  
M Garcia ◽  
A Moreno ◽  
...  

2017 ◽  
Vol 4 (1) ◽  
Author(s):  
Romain Ragonnet ◽  
Sylvie Deuffic-Burban ◽  
Christoph Boesecke ◽  
Marguerite Guiguet ◽  
Karine Lacombe ◽  
...  

Abstract Background Hepatitis C virus (HCV) infection is often asymptomatic, and the date of infection is almost impossible to determine. Furthermore, spontaneous clearance (SC) may occur, but little is known about its time of occurrence. Methods Data on human immunodeficiency virus (HIV)-HCV coinfected individuals were used to inform a stochastic simulation model of HCV viral load kinetics, alanine aminotransferase (ALT), and HCV antibodies during acute hepatitis C. The dates of diagnosis and potential SC were estimated through a Bayesian approach. Hepatitis C virus diagnosis was assumed to be based on an elevated ALT level detected during a control visit for HIV-infected individuals, which occurred every 3 months (scenario A) or every 6 months (scenario B). Results We found that HCV diagnosis occurred after a median of 115 days and 170 days of infection in scenarios A and B, respectively. Among spontaneous clearers, SC occurred after a median time of 184 days after infection. Seven percent (scenario B) to 10% (scenario A) of SCs appeared more than 6 months after diagnosis, and 3% (both scenarios) of SCs appeared more than 1 year after diagnosis. Conclusions Acute hepatitis C diagnosis occurs late in HIV-HCV coinfected individuals. Screening for HCV in HIV-infected individuals should be performed frequently to reduce delays. Our findings about late occurrence of SC support “wait and see” strategies for treatment initiation from an individual basis. However, early treatment initiation may reduce HCV transmission.


Hepatology ◽  
2007 ◽  
Vol 47 (2) ◽  
pp. 407-417 ◽  
Author(s):  
Jean-Charles Duclos-Vallée ◽  
Cyrille Féray ◽  
Mylène Sebagh ◽  
Elina Teicher ◽  
Anne-Marie Roque-Afonso ◽  
...  

2017 ◽  
Vol 4 (2) ◽  
Author(s):  
Giovanni Guaraldi ◽  
Roberto Rossotti ◽  
Gabriella Verucchi ◽  
Marcello Tavio ◽  
Luisa Pasulo ◽  
...  

Abstract This retrospective study reports the data of sofosbuvir-based anti-hepatitis C virus treatment in 24 candidates and 24 recipients of liver transplantation coinfected with human immunodeficiency virus. Sustained virologic response was cumulatively 85% (90% and 100% in those treated with optimal schedules pre- and posttransplant, respectively).


Sign in / Sign up

Export Citation Format

Share Document